APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,058,930 | +150.9% | 185,566 | +500.9% | 0.02% | +150.0% |
| Q2 2023 | $2,813,168 | +42.5% | 30,880 | +3.2% | 0.01% | +50.0% |
| Q1 2023 | $1,974,183 | -76.6% | 29,930 | -81.7% | 0.00% | -78.9% |
| Q4 2022 | $8,450,965 | +454.2% | 163,430 | +631.9% | 0.02% | +375.0% |
| Q3 2022 | $1,525,000 | -75.9% | 22,330 | -84.1% | 0.00% | -73.3% |
| Q2 2022 | $6,338,000 | +210.5% | 140,159 | +248.8% | 0.02% | +275.0% |
| Q1 2022 | $2,041,000 | -49.6% | 40,180 | -53.1% | 0.00% | -50.0% |
| Q4 2021 | $4,047,000 | +4072.2% | 85,589 | +2809.2% | 0.01% | – |
| Q3 2021 | $97,000 | -96.7% | 2,942 | -93.7% | 0.00% | -100.0% |
| Q2 2021 | $2,955,000 | +61.3% | 46,763 | +9.5% | 0.01% | +50.0% |
| Q1 2021 | $1,832,000 | -25.0% | 42,701 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $2,442,000 | +130.8% | 42,701 | +21.8% | 0.01% | +100.0% |
| Q3 2020 | $1,058,000 | +31.9% | 35,045 | +42.7% | 0.00% | +50.0% |
| Q2 2020 | $802,000 | +289.3% | 24,550 | +219.0% | 0.00% | +100.0% |
| Q1 2020 | $206,000 | -34.4% | 7,695 | -24.8% | 0.00% | 0.0% |
| Q4 2019 | $314,000 | – | 10,228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |